Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sangart
ClinicalTrials.gov Identifier:
NCT00421200
First received: January 9, 2007
Last updated: August 15, 2013
Last verified: August 2013